Pamela P Palmer Acelrx Pharmaceuticals Inc (ACRX) insider trading activity

Pamela P Palmer is Chief Medical Officer of ACELRX PHARMACEUTICALS INC. Currently has a direct ownership of 59,149 shares of ACRX, which is worth approximately $66,838. The most recent transaction as insider was on Mar 03, 2024, when has been sold 450 shares (Common Stock) at a price of $1.3 per share, resulting in proceeds of $585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.1K

0% 3M change

92.34% 12M change

Total Value Held $66,838

Pamela P Palmer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2024	SELL Payment of exercise price or tax liability	$585 $1.3 p/Share	450 Reduced 0.76%	59,149 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	18,000 Added 25.23%	53,344 Common Stock
Feb 11 2024	SELL Payment of exercise price or tax liability	$881 $1.1 p/Share	801 Reduced 2.22%	35,344 Common Stock
Feb 10 2024	SELL Payment of exercise price or tax liability	$881 $1.1 p/Share	801 Reduced 2.17%	36,145 Common Stock
Aug 25 2023	SELL Open market or private sale	$8,111 $1.09 p/Share	7,442 Reduced 19.48%	30,753 Common Stock
Aug 24 2023	SELL Open market or private sale	$11,131 $1.17 p/Share	9,514 Reduced 19.94%	38,195 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$746 $1.31 p/Share	570 Reduced 1.3%	43,315 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$1,708 $1.68 p/Share	1,017 Reduced 2.26%	43,885 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	6,125 Added 12.0%	44,902 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$1,375 $2.02 p/Share	681 Reduced 1.73%	38,777 Common Stock
Mar 03 2022	SELL Payment of exercise price or tax liability	$3,248 $0.41 p/Share	7,923 Reduced 1.01%	779,261 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$3,171 $0.4 p/Share	7,927 Reduced 1.01%	777,184 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	122,500 Added 13.5%	785,111 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$4,038 $0.43 p/Share	9,391 Reduced 1.4%	662,611 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	68,750 Added 9.35%	666,621 Common Stock
Feb 11 2021	SELL Payment of exercise price or tax liability	$23,446 $2.63 p/Share	8,915 Reduced 1.48%	593,098 Common Stock
Feb 06 2021	SELL Payment of exercise price or tax liability	$24,382 $2.59 p/Share	9,414 Reduced 1.54%	602,013 Common Stock

PPP

Pamela P Palmer

Chief Medical Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRX shares.

Notify only if

Value

Insider Trading

Get notified when an Acelrx Pharmaceuticals Inc insider buys or sells ACRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACELRX PHARMACEUTICALS INC

Track Activities on ACRX

Account